Does analgesic effect of opium hamper the adverse effects of severe coronary artery disease on quality of life in addicted patients?

Anesthesiology and Pain Medicine

Volumn 2, Issue 1, 2012, Pages 22-27

  Najafi, Mahdi ^a   Sheikhvatan, Mehrdad ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Analgesia; Coronary Artery Disease; Opium; Quality of Life

Indexed keywords

EID: 84900822338     PISSN: 22287523     EISSN: 22287531     Source Type: Journal    
DOI: 10.5812/aapm.5139     Document Type: Article

References (28)

1. Kalant H. Opium revisited: a brief review of its nature, composition, non-medical use and relative risks. Addiction. 1997;92(3):267-77.
2. United Nations Office on Drugs and Crime (UNDOC). World Drug Report 2009. [cited 2012 Apr 10]; Available from: http://www.unodc. org/unodc/en/data-and-analysis/WDR-2009.html.
3. United Nations Office on Drugs and Crime (UNODC) field Office in Iran. Young people and drugs towards a comprehensive health promotion policy Tehran Report. [cited 2012 Apr 10]; Available from: http://www.unodc.org/pdf/iran/publications/ahrn. pdf.
4. Sadeghian H, Sheikhvatan M, Mahmoodian M, Sheikhfathollahi M, Hakki E, Sadeghian A, et al. Comparison of Short-Term Clinical Outcome of Non-ST Elevation versus ST Elevation Myocardial Infarction. J Tehran Heart Cent. 2009;4(2).
5. Najafi M, Sheikhvatan M, Montazeri A. Quality of life-associated factors among patients undergoing coronary artery bypass surgery as measured using the WHOQOL-BREF. Cardiovasc J Afr. 2009;20(5):284-9.
6. Bernabei R, Gambassi G, Lapane K, Landi F, Gatsonis C, Dunlop R, et al. Management of pain in elderly patients with cancer. SAGE Study Group. Systematic Assessment of Geriatric Drug Use via Epidemiology. JAMA. 1998;279(23):1877-82.
7. Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10(2):113-30.
8. Dunn KM, Saunders KW, Rutter CM, Banta-Green CJ, Merrill JO, Sullivan MD, et al. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med. 2010;152(2):85-92.
9. Bizzarri J, Rucci P, Vallotta A, Girelli M, Scandolari A, Zerbetto E, et al. Dual diagnosis and quality of life in patients in treatment for opioid dependence. Subst Use Misuse. 2005;40(12):1765-76.
10. Millson PE, Challacombe L, Villeneuve PJ, Fischer B, Strike CJ, Myers T, et al. Self-perceived health among Canadian opiate users: a comparison to the general population and to other chronic disease populations. Can J Public Health. 2004;95(2):99-103.
11. Smith KW, Larson MJ. Quality of life assessments by adult substance abusers receiving publicly funded treatment in Massachusetts. Am J Drug Alcohol Abuse. 2003;29(2):323-35.
12. Ware JE, Jr., Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care. 1995;33(4 Suppl):AS264-79.
13. Mayer O, Jr., Simon J, Heidrich J, Cokkinos DV, De Bacquer D. Educational level and risk profile of cardiac patients in the EUROASPIRE II substudy. J Epidemiol Community Health. 2004;58(1):47-52.
14. Barrett-Connor E, Giardina EG, Gitt AK, Gudat U, Steinberg HO, Tschoepe D. Women and heart disease: the role of diabetes and hyperglycemia. Arch Intern Med. 2004;164(9):934-42.
15. VandenBos GR. A.P.A. dictionary of psychology. American Psychological Association; 2007.
16. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV-TR. American Psychiatric Publishing, Inc.; 2000.
17. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, et al. European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prev Rehabil. 2003;10(4):S1-S10.
18. Bartnik M, Ryden L, Ferrari R, Malmberg K, Pyorala K, Simoons M, et al. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. Eur Heart J. 2004;25(21):1880-90.
19. Chalmers J, MacMahon S, Mancia G, Whitworth J, Beilin L, Hansson L, et al. 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. Clin Exp Hypertens. 1999;21(5-6):1009-60.
20. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2008;31(Suppl 1):55-60.
21. Scheuner MT, Whitworth WC, McGruder H, Yoon PW, Khoury MJ. Familial risk assessment for early-onset coronary heart disease. Genet Med. 2006;8(8):525-31.
22. Suwanwela C, Poshyachinda V, Tasanapradit P, Dharmkrong-At A. The hill tribes of Thailand, their opium use and addiction. Bull Narc. 1978;30(2):1-19.
23. Karam GA, Reisi M, Kaseb AA, Khaksari M, Mohammadi A, Mahmoodi M. Effects of opium addiction on some serum factors in addicts with non-insulin-dependent diabetes mellitus. Addict Biol. 2004;9(1):53-8.
24. Mohammadi A, Darabi M, Nasry M, Saabet-Jahromi MJ, Malek-Pour-Afshar R, Sheibani H. Effect of opium addiction on lipid profile and atherosclerosis formation in hypercholesterolemic rabbits. Exp Toxicol Pathol. 2009;61(2):145-9.
25. Sesso R, Yoshihiro MM. Time of diagnosis of chronic renal failure and assessment of quality of life in haemodialysis patients. Nephrol Dial Transplant. 1997;12(10):2111-6.
26. Meyer K, Laederach-Hofmann K. Effects of a comprehensive rehabilitation program on quality of life in patients with chronic heart failure. Prog Cardiovasc Nurs. 2003;18(4):169-76.
27. Metra M, Giubbini R, Nodari S, Boldi E, Modena MG, Dei Cas L. Differential effects of beta-blockers in patients with heart failure: A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol. Circulation. 2000;102(5):546-51.
28. Liu Y, Yang YM, Zhu J, Tan HQ, Liang Y, Li JD. Prognostic significance of hemoglobin A1c level in patients hospitalized with coronary artery disease. A systematic review and meta-analysis. Cardiovasc Diabetol. 2011;10:98.